What to Expect From FedEx Earnings
FedEx is scheduled to report its fiscal first-quarter financial results after the markets close on Tuesday.
All Work
Chris Lange
Tobira Therapeutics Skyrockets on Allergan Acquisition
Tobira Therapeutics shares skyrocketed on Tuesday after Allergan announced that it will acquire the company.
Puma Biotech Rises on Key FDA Approval
Shares of Puma Biotechnology had a strong gain in Tuesday’s session following some positive news from the FDA on the company's breast cancer treatment.
Tessera Moves to Acquire DTS
DTS shares saw a handy gain early on Tuesday after it was announced that this company would be acquired by Tessera Technologies).
Activision and Sony Gear Up for Highly Anticipated Destiny Release
Activision Blizzard is set to deliver a highly anticipated expansion in its Destiny franchise, easily one of the most anticipated video game releases in recent history.
Ascena Retail Group Stumbles Over Q4 Earnings and Guidance
This has been a tough fiscal year for Ascena Retail, with significant store traffic headwinds and a competitive selling environment. The stock is down nearly 40% over the past weeks.
Sarepta Scores Big on Highly Contested FDA Approval
Sarepta Therapeutics cleared another hurdle related to its Duchenne muscular dystrophy treatment, and the stock practically doubled on Monday.
Vista Equity Partners Moves to Acquire Infoblox
Infoblox shares made a handy gain on Monday after the company said that it has entered into a definitive agreement to be acquired by Vista Equity Partners.
Community Health May Be Planning Sale
Shares of Community Health Systems retreated on Monday, after making a sizable gain in Friday’s session on news that the company might be pursuing an option to sell.
What Analysts Are Saying About Oracle After Earnings
Despite growing from last year, Oracle took a step back when it failed to reach analysts’ expectations in its fiscal first-quarter financial results on Thursday.
Top 7 Earnings for the Coming Week
24/7 Wall St. has put together a preview of Rite Aid, FedEx and some of the major companies reporting earnings in the coming week.
4 Companies That Destroyed Shareholders Last Week
24/7 Wall Street has picked out a few companies posting the largest losses for the week, including Novavax and VimpelCom.
10 Analyst Stock Picks Under $10 for Massive Upside
One category of analyst calls that often comes with great upside is in the small-cap and low-priced stocks. Some of these stocks trade under $10 per share.
6 Top Oil and Gas Stocks Analysts Want You to Buy
The week of September 12 brought a fair number analyst upgrades and downgrades in oil and gas stocks. Some analysts believe many of the energy stocks continue to be very smart buys, based on…
On Top of Stronger Guidance, Intel Even Talks Up the PC Market
Intel shares saw a handy gain to close out the week after the company raised guidance for its third quarter, due to replenishment of PC supply chain inventory.
Is This the Ultimate Implosion of Novavax?
Novavax was pummeled by shareholders on Friday after the company reported top-line results from its RSV F Vaccine trials.
VimpelCom Prices Secondary Offering
VimpelCom intends to offer more than 142 million shares at $3.50 apiece, in a secondary offering valued up to more than $573 million.
Oracle Stumbles Despite Cloud Growth
After Oracle reported its fiscal first-quarter financial results after the markets closed on Thursday, this networking giant's shares slipped in the after-hours session.
Has AcelRx Pharmaceuticals Hit a Home Run?
Shares of AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX) surged following positive results from a late-stage trial. The company announced the outcome of an open-label Phase 3 trial (SAP303) of investigational product candidate ARX-04. Let us just say, it…
Caladrius Bio Jumps on Private Placement Deal
Caladrius Biosciences watched its shares soar on Thursday after the company announced a private placement offering.